The application of high-content analysis in the study of targeted particulate delivery systems for intracellular drug delivery to alveolar macrophages.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Molecular Pharmaceutics

• Publication date

  2011-05-27

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/mp1004178PMID 21591762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High content analysis of cytotoxic effects of pDMAEMA on human intestinal epithelial and monocyte cultures.

  2010cited by this paper
• Endocytosis of nanomedicines.

  2010cited by this paper
• Development of a high throughput method for screening of novel nanotechnologies for siRNA transfection of airway cells using high content screening (HCS)

  2010cited by this paper
• Development of highly porous large PLGA microparticles for pulmonary drug delivery.

  2009cited by this paper
• The uptake and intracellular fate of PLGA nanoparticles in epithelial cells.

  2009cited by this paper
• Uptake and cytotoxicity of poly(d,l-lactide-co-glycolide) nanoparticles in human colon adenocarcinoma cells

  2009cited by this paper
• Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size.

  2009cited by this paper
• Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages.

  2009cited by this paper
• Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.

  2009cited by this paper
• Drug delivery and nanoparticles: Applications and hazards

  2008cited by this paper
• Delivery systems to increase the selectivity of antibiotics in phagocytic cells.

  2008cited by this paper
• A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins.

  2008cited by this paper
• Phagocytic activity of alveolar macrophages toward polystyrene latex microspheres and PLGA microspheres loaded with anti-tuberculosis agent.

  2007cited by this paper
• Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages.

  2007cited by this paper
• Biodegradable nanoparticles for cytosolic delivery of therapeutics.

  2007cited by this paper
• A Caspase-Independent Pathway Mediates Macrophage Cell Death in Response to Mycobacterium tuberculosis Infection

  2007cited by this paper
• Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway

  2006cited by this paper
• High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening

  2006cited by this paper
• Cellular imaging in drug discovery

  2006cited by this paper
• Increased intracellular targeting to airway cells using octaarginine-coated liposomes: in vitro assessment of their suitability for inhalation.

  2006cited by this paper
• High-throughput fluorescence microscopy for systems biology

  2006cited by this paper
• In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localisation.

  2006cited by this paper
• A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen.

  2006cited by this paper
• Genome scale cytometry: High content analysis for high throughput RNAi phenotype profiling.

  2005cited by this paper
• Image-based screening: a technology in transition.

  2005cited by this paper
• Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model.

  2005cited by this paper
• THP-1 Cell Apoptosis in Response to Mycobacterial Infection

  2003cited by this paper
• Confocal optics microscopy for biochemical and cellular high-throughput screening.

  2003cited by this paper
• Advancing the field of drug delivery: taking aim at cancer.

  2003cited by this paper
• Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

  2002cited by this paper
• Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?

  2001cited by this paper
• Inhalable Microparticles Containing Drug Combinations to Target Alveolar Macrophages for Treatment of Pulmonary Tuberculosis

  2001cited by this paper
• Preparation and characterization of gelatin surface modified PLGA microspheres

  2001cited by this paper
• In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates.

  2000cited by this paper
• Desolvation process and surface characterisation of protein nanoparticles.

  2000cited by this paper
• Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine.

  1998cited by this paper
• Large porous particles for pulmonary drug delivery.

  1997cited by this paper
• Albumin Microspheres as a Drug Delivery System: Relation Among Turbidity Ratio, Degree of Cross-linking, and Drug Release

  1993cited by this paper
• Protein Precoating of Polylactide Microspheres Containing a Lipophilic Immunopotentiator for Enhancement of Macrophage Phagocytosis and Activation

  1989cited by this paper
• Phagocytosis of opsonized fluorescent microspheres by human neutrophils. A two-color flow cytometric method for the determination of attachment and ingestion.

  1988cited by this paper
• Phagocytosis: flow cytometric quantitation with fluorescent microspheres.

  1982cited by this paper

• miR-421-Loaded Chitosan Nanoparticles Suppress the Malignant Characteristics of Colorectal Cancer Cells

  2024cites this paper
• Biomimetic Systems Involving Macrophages and Their Potential for Targeted Drug Delivery

  2023cites this paper
• Lipid-based particle engineering via spray-drying for targeted delivery of antibiotics to the lung.

  2023cites this paper
• THP-1 cell line model for tuberculosis: A platform for in vitro macrophage manipulation.

  2022cites this paper
• Polymer Applications in Pulmonary Drug Delivery

  2021cites this paper
• Recombinant ArgF PLGA nanoparticles enhances BCG induced immune responses against Mycobacterium bovis infection.

  2021cites this paper
• Cationic inhalable particles for enhanced drug delivery to M. tuberculosis infected macrophages

  2021cites this paper
• Alveolar macrophages: novel therapeutic targets for respiratory diseases

  2021cites this paper
• Extracellular matrix-inspired inhalable aerogels for rapid clearance of pulmonary tuberculosis.

  2021cites this paper
• Pulmonary Delivery of Isoniazid in Nanogel-Loaded Chitosan Hybrid Microparticles for Inhalation

  2019cites this paper
• Inhalable poly(lactic‐co‐glycolic acid) (PLGA) microparticles encapsulating all‐trans‐Retinoic acid (ATRA) as a host‐directed, adjunctive treatment for Mycobacterium tuberculosis infection

  2019cites this paper
• Modified cells as potential ocular drug delivery systems.

  2019cites this paper
• Nanomodulation of Macrophages in Multiple Sclerosis

  2019cites this paper
• In vitro toxicity screening of polyglycerol esters of fatty acids as excipients for pulmonary formulations.

  2019cites this paper
• Knockdown of Gene Expression in Macrophages by microRNA Mimic-Containing Poly (Lactic-co-glycolic Acid) Microparticles

  2018cites this paper
• Residence time and uptake of porous and cationic maltodextrin‐based nanoparticles in the nasal mucosa: Comparison with anionic and cationic nanoparticles

  2018cites this paper
• Antibacterial Loaded Spray Dried Chitosan Polyelectrolyte Complexes as Dry Powder Aerosol for the Treatment of Lung Infections

  2017cites this paper
• Local delivery of siRNA-loaded calcium phosphate nanoparticles abates pulmonary inflammation

  2017cites this paper
• Sharpening nature's tools for efficient tuberculosis control: A review of the potential role and development of host-directed therapies and strategies for targeted respiratory delivery.

  2016cites this paper
• Gelatin Nanoparticles with Enhanced Affinity for Calcium Phosphate.

  2016cites this paper
• Dual-functionalisation of gelatine nanoparticles with an anticancer platinum(II)–bisphosphonate complex and mineral-binding alendronate

  2016cites this paper
• Treatment of Mycobacterium tuberculosis-Infected Macrophages with Poly(Lactic-Co-Glycolic Acid) Microparticles Drives NFκB and Autophagy Dependent Bacillary Killing

  2016cites this paper
• Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation.

  2016cites this paper
• High-content analysis for drug delivery and nanoparticle applications.

  2015cites this paper
• High-throughput methods for screening liposome–macrophage cell interaction

  2015cites this paper
• Non-genetic engineering of cells for drug delivery and cell-based therapy.

  2015cites this paper
• Therapeutic aerosol bioengineering of siRNA for the treatment of inflammatory lung disease by TNFα gene silencing in macrophages.

  2014cites this paper
• Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis.

  2014cites this paper
• Early-Stage Development of Novel Cyclodextrin-siRNA Nanocomplexes Allows for Successful Postnebulization Transfection of Bronchial Epithelial Cells

  2014cites this paper
• Testing nanoparticles for angiogenesis-related disease: charting the fastest route to the clinic.

  2014cites this paper
• 'Smart' non-viral delivery systems for targeted delivery of RNAi to the lungs.

  2013cites this paper
• Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis.

  2013cites this paper
• A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth disease.

  2012cites this paper
• Therapeutic aerosol bioengineering of targeted, inhalable microparticle formulations to treat Mycobacterium tuberculosis (MTb)

  2011influential citation
• Development of Nano- and Microparticle Technologies for Targeted Gene Silencing through RNA Interference Manipulation of the Immune Response in Inflammatory Lung Disease

  2011cites this paper
• RNA interference in respiratory disease

  2010cites this paper